| 摘要 |
The active, galactose binding site of proteins associated with metastatic tumor cells has been identified and sequenced (SEQ ID No:1). The polypeptide comprising the active site may be used as an immunotherapeutic agent. Identification of the site makes possible an in vivo diagnostic assay for metastatic cells as well as therapeutic methodologies and materials.
|
